Tabula Rasa HealthCare, Inc.
TRHCDelisted Nov 3, 2023- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001651561
Tabula Rasa HealthCare, Inc. was delisted on Nov 3, 2023; its insiders filed their last Form 4 on Nov 14, 2023; 84 institutions reported holding it in 13F filings for Q3 2023, worth $168.0M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:50 PM ET
Revenue flow, FY2022
Where the revenue went in FY2022, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2022: $147.5M (49.2% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 17, 2023 | Feb 25, 2022 | Jan 12, 2021 | Feb 27, 2020 | Mar 1, 2019 |
| Revenue | $299.5M | $331.3M | $297.2M | $284.7M | $204.3M |
| Cost of revenue | $232.6M | $233.4M | $204.8M | $181.4M | $137.7M |
| Operating expenses | $135.9M | $167.2M | $157.8M | $136.0M | $116.3M |
| Research and development | $14.5M | $19.8M | $18.2M | $21.7M | $12.2M |
| Selling, general and administrative | $75.0M | $73.8M | $65.4M | $50.9M | $28.2M |
| Operating income | -$69.0M | -$69.3M | -$65.4M | -$32.6M | -$49.7M |
| Interest expense | – | $9.11M | $20.7M | $16.0M | $906.0K |
| Income tax | $389.0K | $627.0K | -$5.17M | -$16.2M | -$3.38M |
| Net income | -$147.5M | -$79.1M | -$81.0M | -$32.4M | -$47.3M |
| EPS, basic | $-6.07 | $-3.39 | – | $-1.57 | $-2.48 |
| EPS, diluted | $-6.07 | $-3.39 | – | $-1.57 | $-2.48 |
| Weighted shares, basic | 24.3M | 23.3M | – | 20.6M | 19.1M |
| Weighted shares, diluted | 24.3M | 23.3M | – | 20.6M | 19.1M |
| Margins and growth | |||||
| Operating margin | -23.0% | -20.9% | -22.0% | -11.5% | -24.3% |
| Net margin | -49.2% | -23.9% | -27.2% | -11.4% | -23.1% |
| Revenue growth, year over year | −9.6% | +11.5% | +4.4% | +39.4% | +51.8% |
| Net income growth, year over year | – | – | – | – | −430.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 17, 2023 | Feb 25, 2022 | Jan 12, 2021 | Feb 27, 2020 | Mar 1, 2019 |
| Cash and equivalents | $70.0M | $9.67M | $23.4M | $42.5M | $20.3M |
| Accounts receivable | $19.3M | $34.1M | $32.5M | $29.1M | $27.9M |
| Inventory | $6.57M | $5.44M | $4.26M | $3.70M | $3.59M |
| Total current assets | $170.3M | $89.9M | $93.2M | $94.5M | $63.3M |
| Property, plant and equipment | – | – | – | $15.8M | $11.9M |
| Goodwill | $115.3M | $170.8M | $170.9M | $150.8M | $108.2M |
| Intangible assets | $38.3M | $154.7M | $183.1M | $189.4M | $77.2M |
| Total assets | $384.1M | $499.4M | $514.4M | $492.4M | $271.0M |
| Accounts payable | $19.5M | $13.2M | $11.2M | $8.62M | $14.8M |
| Total current liabilities | $102.1M | $73.9M | $72.2M | $40.0M | $75.7M |
| Long-term debt | – | – | – | $226.3M | – |
| Total liabilities | $441.2M | $443.7M | $345.9M | $306.8M | $131.9M |
| Shareholders' equity | -$57.0M | $55.8M | $168.5M | $185.5M | $139.0M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 17, 2023 | Feb 25, 2022 | Jan 12, 2021 | Feb 27, 2020 | Mar 1, 2019 |
| Operating cash flow | $7.36M | $15.5M | $4.82M | -$5.82M | $15.8M |
| Capital expenditures | $2.29M | $3.35M | $3.09M | $7.47M | $4.99M |
| Free cash flow | $5.07M | $12.1M | $1.73M | -$13.3M | $10.8M |
| Depreciation and amortization | $23.3M | $47.7M | $45.0M | $34.3M | $16.8M |
| Stock-based compensation | $32.4M | $38.5M | $32.6M | $27.3M | $10.4M |
| Share buybacks | – | – | – | – | $2.87M |
| Investing cash flow | $91.3M | -$35.2M | -$28.7M | -$180.9M | -$43.8M |
| Financing cash flow | -$32.0M | $6.92M | $5.87M | $208.3M | $42.6M |
| Net change in cash | $66.7M | -$12.8M | -$18.0M | $21.6M | $14.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 10.8% | 11.6% | 11.0% | 9.6% | 5.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Jul 28, 2023 | 27.1M | +3.1% | SEC |
| Apr 30, 2023 | 26.9M | +3.9% | SEC |
| Feb 28, 2023 | 26.9M | +4.4% | SEC |
| Oct 15, 2022 | 27.1M | +5.5% | SEC |
| Jul 29, 2022 | 26.3M | +4.9% | SEC |
| Apr 30, 2022 | 25.8M | +4.0% | SEC |
| Feb 16, 2022 | 25.7M | +4.3% | SEC |
| Oct 31, 2021 | 25.7M | +7.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.